Pulmonary abscess due to leflunomide use in rheumatoid arthritis:: a case report

被引:8
|
作者
Ulusoy, H
Bilgici, A [1 ]
Kuru, O
Çelenk, Ç
机构
[1] Ondokuz Mayis Univ, Fac Med, Dept Phys Med & Rehabil, TR-55139 Samsun, Turkey
[2] Ondokuz Mayis Univ, Fac Med, Dept Radiol, Samsun, Turkey
关键词
infection; leflunomide; pulmonary abscess; rheumatoid arthritis;
D O I
10.1007/s00296-004-0493-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 43-year-old woman had rheumatoid arthritis (RA) for 5 years and complained of fever, arthralgia/ myalgia, and night sweating for a month. She had been receiving only leflunomide (20 mg/day) for 5 months. On admission, there was no evidence of active arthritis or vasculitic lesion. Laboratory evaluation showed an erythrocyte sedimentation rate of 145 mm/h and C-reactive protein of 160 mg/dl. All cultures were negative. Chest radiograph and computed tomography (CT) revealed a pulmonary abscess. Staphylococcus aureus multiplied in the culture of a purulent sample obtained from the abscess under ultrasonography. The leflunomide was stopped, and sultamicillin (IV 4x2 g/day) was started for a further 6 weeks. Four weeks later, the patient had completely recovered and CT showed significant improvement of the pulmonary abscess. Ten milligrams/day of prednisolone and 7.5 mg/week of methotrexate were started for RA treatment. The patient has been under control for 5 months without any further abscess or RA activation.
引用
收藏
页码:139 / 142
页数:4
相关论文
共 50 条
  • [31] Evaluation of effectiveness of leflunomide in the treatment of rheumatoid arthritis
    Eser, Filiz
    Bodur, Hatice
    Aktekin, Lale Akbulut
    Seckin, Uemit
    ROMATIZMA-RHEUMATISM, 2008, 23 (02): : 52 - 55
  • [32] Management of rheumatoid arthritis - Defining the role of leflunomide
    Carswell, CI
    Perry, CM
    Ibbotson, T
    DISEASE MANAGEMENT & HEALTH OUTCOMES, 2003, 11 (11) : 745 - 765
  • [33] Leflunomide in the treatment of rheumatoid arthritis
    Li, EK
    Tam, LS
    Tomlinson, B
    CLINICAL THERAPEUTICS, 2004, 26 (04) : 447 - 459
  • [34] Hepatotoxicity secondary to leflunomide in rheumatoid arthritis patient
    Salouage, I.
    Tekaya, R.
    Gaies, E.
    Charfi, R.
    Trabelsi, S.
    Lakhal, M.
    Klouz, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 61 - 61
  • [35] Effect of leflunomide on the peripheral nerves in rheumatoid arthritis
    Richards, B. L.
    Spies, J.
    McGill, N.
    Richards, G. W.
    Vaile, J.
    Bleasel, J. F.
    Youssef, P. P.
    INTERNAL MEDICINE JOURNAL, 2007, 37 (02) : 101 - 107
  • [36] Efficacy and safety of leflunomide in active rheumatoid arthritis
    Smolen, JS
    Emery, P
    RHEUMATOLOGY, 2000, 39 : 48 - 56
  • [37] Individualization of leflunomide dosing in rheumatoid arthritis patients
    Hopkins, Ashley M.
    O'Doherty, Catherine E.
    Foster, David J. R.
    Upton, Richard N.
    Proudman, Susanna M.
    Wiese, Michael D.
    PERSONALIZED MEDICINE, 2014, 11 (04) : 449 - 461
  • [38] Severe pancytopenia after leflunomide in rheumatoid arthritis
    Auer, J
    Hinterreiter, M
    Allinger, S
    Kirchgatterer, A
    Knoflach, P
    ACTA MEDICA AUSTRIACA, 2000, 27 (04) : 131 - 132
  • [39] Modelling the costs and effects of leflunomide in rheumatoid arthritis
    Kobelt G.
    Lindgren P.
    Young A.
    The European Journal of Health Economics, 2002, 3 (3) : 180 - 187
  • [40] Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritis
    Henes, Joerg Christoph
    Schedel, Joerg
    Kanz, Lothar
    Koetter, Ina
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (05) : 709 - 712